Dicerna Pharmaceuticals Inc (OQ:DRNA)

Latest 10 SEC filings (by transaction date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 21/19 Nov 21/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -351,505 $22.98
Nov 21/19 Nov 20/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -265,505 $22.93
Nov 21/19 Nov 19/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -397,183 $23.92
Nov 21/19 Nov 19/19 Bain Capital Life Sciences Investors, LLC Indirect Ownership Common Stock S - Open market or private sale -1,750,000 $22.03
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $24.00
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $3.42
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $22.00
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $3.42
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 21/19 Nov 21/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -351,505 $22.98
Nov 21/19 Nov 20/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -265,505 $22.93
Nov 21/19 Nov 19/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -397,183 $23.92
Nov 21/19 Nov 19/19 Bain Capital Life Sciences Investors, LLC Indirect Ownership Common Stock S - Open market or private sale -1,750,000 $22.03
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $24.00
Nov 20/19 Nov 19/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $3.42
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $22.00
Nov 20/19 Nov 18/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $3.42
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $DRNA

StockTwits